The acutely decompensated right ventricle: Pathways for diagnosis and management

Chest

Volumn 128, Issue 3, 2005, Pages 1836-1852

  Piazza, Gregory ^a   Goldhaler, Samuel Z ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cor pulmonale; Diagnosis; Management; Pathophysiology; Prognosis; Right ventricular dysfunction; Right ventricular failure

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BOSENTAN; CALCIUM SENSITIZER; DOBUTAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; HYPERTENSIVE AGENT; INFUSION FLUID; INOTROPIC AGENT; ISOPRENALINE; LEVOSIMENDAN; MILRINONE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN E1; SILDENAFIL; VASODILATOR AGENT; VASOPRESSIN;

AORTA BALLOON; ARTIFICIAL VENTILATION; COR PULMONALE; CRITICAL ILLNESS; DIAGNOSTIC IMAGING; DISEASE PREDISPOSITION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE OVERLOAD; HEART SURGERY; HEART TRANSPLANTATION; HEART VENTRICLE CONTRACTILITY; HEMODYNAMICS; HUMAN; HYPOTENSION; LIVER TOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TECHNOLOGY;

EID: 24944445038     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.3.1836     Document Type: Article

References (77)

1. Jardin F, Brun-Ney D, Auvert B, et al. Sepsis-related cardiogenic shock. Crit Care Med 1990; 18:1055-1060
2. Vieillard-Baron A, Prin S, Chergui K, et al. Hemodynamic instability in sepsis: bedside assessment by Doppler echocardiography. Am J Respir Crit Care Med 2003; 168:1270-1276
3. Jardin F, Gueret P, Dubourg O, et al. Two-dimensional echocardiographic evaluation of right ventricular size and contractility in acute respiratory failure. Crit Care Med 1985; 13:952-956
4. Vieillard-Baron A, Schmitt JM, Augarde R, et al. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med 2001; 29:1551-1555
5. Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001; 38:923-931
6. Jardin F, Vieillard-Baron A. Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings. Intensive Care Med 2003; 29:1426-1434
7. Goldstein JA. Pathophysiology and management of right heart ischemia. J Am Coll Cardiol 2002; 40:841-853
8. Pfisterer M. Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet 2003; 362:392-394
9. Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121: 877-905
10. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J 1995; 130: 1276-1282
11. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: Part I. Epidemiology, pathophysiology, and diagnosis. Circulation 2003; 108:2726-2729
12. Jardin F, Dubourg O, Gueret P, et al. Quantitative two-dimensional echocardiography in massive pulmonary embolism: emphasis on ventricular interdependence and leftward septal displacement. J Am Coll Cardiol 1987; 10:1201-1206
13. Jardin F, Dubourg O, Bourdarias JP. Echocardiographic pattern of acute cor pulmonale. Chest 1997; 111:209-217
14. McNeil K, Dunning J, Morrell NW. The pulmonary physician in critical care: 13. The pulmonary circulation and right ventricular failure in the ITU. Thorax 2003; 58:157-162
15. Louie EK, Lin SS, Reynertson SI, et al. Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. Circulation 1995; 92:819-824
16. Palevsky HI, Fishman AP. Chronic cor pulmonale: etiology and management. JAMA 1990; 263:2347-2353
17. Kucher N, Walpoth N, Wustmann K, et al. Qr in V1: an ECG sign associated with ischemia and right ventricular dysfunction in pulmonary embolism [abstract]. Circulation 2002; 106:459
18. Kinch JW, Ryan TJ. Right ventricular infarction. N Engl J Med 1994; 330:1211-1217
19. Boxt LM. Radiology of the right ventricle. Radiol Clin North Am 1999; 37:379-400
20. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350:647-654
21. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655-663
22. Kucher N, Goldhaber SZ, Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003; 108:2191-2194
23. Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106:1263-1268
24. Giannitsis E, Muller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102:211-217
25. Janata K, Holzer M, Laggner AN, et al. Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. BMJ 2003; 326:312-313
26. Pruszczyk P, Kostrubiec M, Bochowiez A, et al. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 2003; 22:649-653
27. Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest 2003; 123: 1947-1952
28. Meyer T, Binder L, Hruska N, et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000; 36: 1632-1636
29. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107:2545-2547
30. Kucher N, Printzen G, Doernhoefer T, et al. Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation 2003; 107:1576-1578
31. ten Wolde M, Tulevski II, Mulder JW, et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 2003; 107:2082-2084
32. Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31:202-208
33. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000; 102:865-870
34. Leuchte HH, Holzapfel M, Baumgartner RA, et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol 2004; 43:764-770
35. Vlahakes GJ, Turley K, Hoffman JI. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 1981; 63:87-95
36. Adams JE III, Siegel BA, Goldstein JA, et al. Elevations of CK-MB following pulmonary embolism: a manifestation of occult right ventricular infarction. Chest 1992; 101:1203-1206
37. Hama N, Itoh H, Shirakami G, et al. Bapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995; 92:1558-1564
38. Dabestani A, Mahan G, Gardin JM, et al. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol 1987; 59:662-668
39. Nagueh SF, Kopelen HA, Zoghbi WA. Relation of mean right atrial pressure to echoeardiographic and Doppler parameters of right atrial and right ventricular function. Circulation 1996; 93:1160-1169
40. Vieillard-Baron A, Prin S, Chergui K, et al. Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit. Am J Respir Crit Care Med 2002; 166:1310-1319
41. McConnell MV, Solomon SD, Bayan ME, et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996; 78:469-473
42. Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989; 80:353-360
43. Hinderliter AL, Willis PWT, Long W, et al. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension: PPH Study Group; primary pulmonary hypertension. Am J Cardiol 1999; 84:481-484, A410
44. Kwong RY, Schussheim AE, Rekhraj S, et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003; 107:531-537
45. Lorell B, Grossraan W. Profiles in pericarditis, restrictive cardiomyopathy, and cardiac tamponade. In: Baim D, Grossman W, eds. Grossman's cardiac catheterization, angiography, and intervention. 6th ed. Philadelphia, PA: Lippincott, Williams, and Wilkins, 2000
46. Grossman W. Profiles in valvular heart disease. In: Baim D, Grossman W, eds. Grossman's cardiac catheterization, angiography, and intervention. 6th ed. Philadelphia, PA: Lippincott, Williams, and Wilkins, 2000
47. Goldhaber SZ. Profiles in pulmonary embolism. In: Baim D, Grossman W, eds. Grossman's cardiac catheterization, angiography, and intervention. 6th ed. Philadelphia, PA: Lippincott, Williams, and Wilkins, 2000
48. Baker BJ, Wilen MM, Boyd CM, et al. Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. Am J Cardiol 1984; 54:596-599
49. Polak JF, Holman BL, Wynne J, et al. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol 1983; 2:217-224
50. Aklog L. Williams CS, Byrne JG, et al. Acute pulmonary embolectomy: a contemporary approach. Circulation 2002; 105:1416-1419
51. Come PC, Kim D, Parker JA, et al. Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. J Am Coll Cardiol 1987; 10:971-978
52. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341:507-511
53. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-1150
54. Vieillard-Baron A, Page B, Augarde R, et al. Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 2001; 27:1481-1486
55. Fedullo PF, Auger WR, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001; 345: 1465-1472
56. Sugimoto T, Okada M, Yamashita C, et al. Surgical assessment of tricuspid valve replacement for severe tricuspid regurgitation without stenosis. Ann Thorac Cardiovasc Surg 1999; 5:300-303
57. Lavish DT, Tapson VF. Pharmacologic hemodynamic support in massive pulmonary embolism. Chest 1997; 111:218-224
58. Ducas J, Prewitt RM. Pathophysiology and therapy of right ventricular dysfunction due to pulmonary embolism. Cardiovasc Clin 1987; 17:191-202
59. Goldhaber SZ. The approach to massive pulmonary embolism. Semin Respir Crit Care Med 2000; 21:555-561
60. Gold J, Cullinane S, Chen J, et al. Vasopressin in the treatment of murinone-induced hypotension in severe heart failure. Am J Cardiol 2000; 85:506-508, A511
61. Mebazaa A, Karpati P, Renaud E, et al. Acute right ventricular failure: from pathophysiology to new treatments. Intensive Care Med 2004; 30:185-196
62. Haikala H, Nissinen E, Etemadzadeh E, et al. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 1995; 25:794-801
63. Ukkonen H, Saraste M, Akkila J, et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 2000; 68:522-531
64. Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360:196-202
65. Slawsky MT, Colucci WS, Gottlieb SS, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure: study investigators. Circulation 2000; 102:2222-2227
66. D'Ambra MN, LaRaia PJ, Philbin DM, et al. Prostaglandin E1: a new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg 1985; 89:567-572
67. Fierobe L, Brunet F, Dhainant JF, et al. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151: 1414-1419
68. Bhorade S, Christenson J, O'Connor M, et al. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 1999; 159:571-579
69. Michelakis ED, Tymchak W, Noga M, et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 2003; 108:2066-2069
70. Ghofrani HA, Wiedemann R, Rose F, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002; 136:515-522
71. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903
72. Galie N, Hinderliter AL, Torbicki A, et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol 2003; 41: 1380-1386
73. Sano S, Ishino K, Kawada M, et al. Total right ventricular exclusion procedure: an operation for isolated congestive right ventricular failure. J Thorac Cardiovasc Surg 2002; 123:640-647
74. Takagaki M, Ishino K, Kawada M, et al. Total right ventricular exclusion improves left ventricular function in patients with end-stage congestive right ventricular failure. Circulation 2003; 108(suppl):II226-II229
75. Kaul T, Kahn D. Postinfarct refractory right ventricle: right ventricular exclusion; a possible option to mechanical cardiac support, in patients unsuitable for heart transplant. J Cardiovasc Surg 2000; 41:349-355
76. Morgan JA, John R, Lee BJ, et al. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004; 77:859-863
77. Hines RL. Management of acute right ventricular failure. J Card Surg 1990; 5:285-287